CYBR CyberCare the new look of healthcare Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare

CYBR 446.46

+2.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kevin Podsiadlik who wrote (2275)	6/20/2000 10:41:00 AM
From: Tadsamillionaire	Read Replies (1) of 3392

Value of the patents.... MMMMMMMMMMM .. I would say extraordinarily valuable to any one interested in med tech and break throughs into the " New Medicine".IMHO of course. As far as the marketing of the product. sales are made when a company owns the licensing and patent rights to a product that will change the face of an industry and take the lead in that industry. The FDA approval was secondary to the actual talk, and marketing of the product. It is my opinion in a market such as this , that the company was only promoting their new found fame and the fact that they own the patent. How many times has a product come to market, in a competitive market, not licensed, and been promoted. Also Herb is overlooking the fact that....... ( The product is not sold until it is delivered.) And the fact that on all the press releases I can find , the company states the obvious. "That FDA approval is pending and these are all forward looking statements." Again I ask you..... Who would you believe... Nortel, or Herb?????? I am long on CYBR .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next